These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 21621174)

  • 1. Pityriasis rosea following influenza (H1N1) vaccination.
    Chen JF; Chiang CP; Chen YF; Wang WM
    J Chin Med Assoc; 2011 Jun; 74(6):280-2. PubMed ID: 21621174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent pityriasis rosea: A case report.
    Li A; Li P; Li Y; Li W
    Hum Vaccin Immunother; 2018 Apr; 14(4):1024-1026. PubMed ID: 29182459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of Pityriasis rosea concurrent with the novel influenza A (H1N1) infection.
    Mubki TF; Bin Dayel SA; Kadry R
    Pediatr Dermatol; 2011; 28(3):341-2. PubMed ID: 20403114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pityriasis Rosea-like eruptions following COVID-19 mRNA-1273 vaccination: A case report and literature review.
    Wang CS; Chen HH; Liu SH
    J Formos Med Assoc; 2022 May; 121(5):1003-1007. PubMed ID: 35012825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pityriasis-rosea-like eruption following smallpox vaccination.
    WITHERSPOON FG; THIBODAUX DJ
    AMA Arch Derm; 1957 Jul; 76(1):109-10. PubMed ID: 13434484
    [No Abstract]   [Full Text] [Related]  

  • 6. Manifestation of pityriasis rosea and pityriasis rosea-like eruptions after Covid-19 vaccine: A systematic review.
    Khan I; Elsanousi AA; Shareef AM; Tebha SS; Arif A; Gul S
    Immun Inflamm Dis; 2023 Apr; 11(4):e804. PubMed ID: 37102660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The reporting completeness of a passive safety surveillance system for pandemic (H1N1) 2009 vaccines: a capture-recapture analysis.
    Huang WT; Huang WI; Huang YW; Hsu CW; Chuang JH
    Vaccine; 2012 Mar; 30(12):2168-72. PubMed ID: 22265861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can influenza H1N1 vaccination lead to the membranous glomerulonephritis?
    Kutlucan A; Gonen I; Yildizhan E; Aydin Y; Sav T; Yildirim U
    Indian J Pathol Microbiol; 2012; 55(2):239-41. PubMed ID: 22771654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pityriasis Rosea Associated With COVID-19 Vaccination: A Common Rash Following Administration of a Novel Vaccine.
    Valk B; Bender B
    Cutis; 2021 Dec; 108(6):317-318. PubMed ID: 35167784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel influenza a (H1N1) virus as a possible cause of pityriasis rosea?
    Kwon NH; Kim JE; Cho BK; Park HJ
    J Eur Acad Dermatol Venereol; 2011 Mar; 25(3):368-9. PubMed ID: 20561127
    [No Abstract]   [Full Text] [Related]  

  • 11. A/H1N1 pandemic influenza vaccination: A retrospective evaluation of adverse maternal, fetal and neonatal outcomes in a cohort of pregnant women in Italy.
    Fabiani M; Bella A; Rota MC; Clagnan E; Gallo T; D'Amato M; Pezzotti P; Ferrara L; Demicheli V; Martinelli D; Prato R; Rizzo C
    Vaccine; 2015 May; 33(19):2240-2247. PubMed ID: 25820060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Encephalitis related to a H1N1 vaccination: case report and review of the literature.
    Ussel IV; Boer W; Parizel P; Cras P; Jorens PG
    Clin Neurol Neurosurg; 2014 Sep; 124():8-15. PubMed ID: 24996055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel influenza a (H1N1) virus as a possible cause of pityriasis rosea? A comment.
    Rebora AE; Drago F
    J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):991-2; author reply 991. PubMed ID: 21585559
    [No Abstract]   [Full Text] [Related]  

  • 14. Maculopapular eruptions following COVID-19 vaccination: Pityriasis rosea or pityriasis rosea-like eruptions?
    Ciccarese G; Mastrolonardo M; Serviddio G; Drago F
    J Cosmet Dermatol; 2023 Sep; 22(9):2380-2381. PubMed ID: 37382032
    [No Abstract]   [Full Text] [Related]  

  • 15. Severe serum sickness after H1N1 influenza vaccination.
    Bonds RS; Kelly BC
    Am J Med Sci; 2013 May; 345(5):412-3. PubMed ID: 23221512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse events associated with the 2009 H1N1 influenza vaccination and the vaccination coverage rate in health care workers.
    Park SW; Lee JH; Kim ES; Kwak YG; Moon CS; Yeom JS; Lee JH; Lee CS
    Am J Infect Control; 2011 Feb; 39(1):69-71. PubMed ID: 21122948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pityriasis rosea, pityriasis rosea-like eruptions, and herpes zoster in the setting of COVID-19 and COVID-19 vaccination.
    Drago F; Broccolo F; Ciccarese G
    Clin Dermatol; 2022; 40(5):586-590. PubMed ID: 35093476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis.
    Salmon DA; Proschan M; Forshee R; Gargiullo P; Bleser W; Burwen DR; Cunningham F; Garman P; Greene SK; Lee GM; Vellozzi C; Yih WK; Gellin B; Lurie N;
    Lancet; 2013 Apr; 381(9876):1461-8. PubMed ID: 23498095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immediate hypersensitivity reactions following monovalent 2009 pandemic influenza A (H1N1) vaccines: reports to VAERS.
    Halsey NA; Griffioen M; Dreskin SC; Dekker CL; Wood R; Sharma D; Jones JF; LaRussa PS; Garner J; Berger M; Proveaux T; Vellozzi C; ; Broder K; Setse R; Pahud B; Hrncir D; Choi H; Sparks R; Williams SE; Engler RJ; Gidudu J; Baxter R; Klein N; Edwards K; Cano M; Kelso JM
    Vaccine; 2013 Dec; 31(51):6107-12. PubMed ID: 24120547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse effects following pandemic influenza (H1N1) 2009 vaccination.
    Bolam B; Grills N
    Aust N Z J Public Health; 2009 Dec; 33(6):584. PubMed ID: 20078579
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.